title: Specific effect of anti-transferrin antibodies on natural killer cells directed against tumor cells. Evidence for the transferrin receptor being one of the target structures recognized by NK cells.
abstract: Treatment of PBL or Percoll-isolated LGL with anti-transferrin antibodies plus complement reduced their natural killing activity against K-562 cells between 30 and 70%. The same antibodies inhibited natural cytotoxicity when added directly to the assay. Similar depletion or inhibition of NK cytotoxicity was observed when using HeLa cells as targets. The decrease or inhibition by transferrin antibodies was less marked when IFN-treated PBL or LGL as effector cells were used. The inhibition of anti-transferrin antibodies seems to be located at the level of the effector cell population. When PBL but not target K-562 cells were pretreated with anti-transferrin antibodies and were washed before use in the assay, cytotoxicity was decreased by 50%. In addition, about 80% of the LGL positively selected on anti-transferrin plates stained with Leu-11. Furthermore, no reduction by anti-transferrin antibodies plus complement treatment of PBL or LGL, or inhibition by antibodies alone, was observed when the cells were tested against HSV-1-infected cells. Membrane extracts from LGL inhibited NK cytotoxicity against K-562 or HeLa cells. Moreover, the inhibitory component of this extract was removed by anti-transferrin IgG but not by control IgG. These results are in agreement with the recent hypothesis that NK cells recognize the transferrin receptor in tumor target cells, because both the transferrin receptor and anti-transferrin antibodies may share a similar structure that interacts with the NK cells.
authors.forename: B
authors.initials: B
authors.lastname: Alarcón
authors.forename: M
authors.initials: M
authors.lastname: Fresno
mesh_terms: D000328:Adult; D000818:Animals; D000906:Antibodies / Q000502:physiology*; D000918:Antibody Specificity; D000937:Antigen-Antibody Reactions; D001667:Binding, Competitive; D003602:Cytotoxicity, Immunologic; D005347:Fibroblasts / Q000276:immunology; D006367:HeLa Cells / Q000276:immunology; D006801:Humans; D007694:Killer Cells, Natural / Q000145:classification / Q000276:immunology* / Q000378:metabolism; D004915:Leukemia, Erythroblastic, Acute / Q000276:immunology; D008565:Membrane Proteins / Q000502:physiology; D011817:Rabbits; D011956:Receptors, Cell Surface / Q000378:metabolism*; D011990:Receptors, Transferrin; D018139:Simplexvirus / Q000276:immunology; D014168:Transferrin / Q000276:immunology* / Q000378:metabolism
chemical_list: D000906:Antibodies; D008565:Membrane Proteins; D011956:Receptors, Cell Surface; D011990:Receptors, Transferrin; D014168:Transferrin